Plain-English translation of NCT05700149 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying nodal marginal zone lymphoma — a type of blood cancer affecting lymph nodes — by analyzing tumor tissue and medical records from patients already diagnosed with this condition. The study will examine the genetic and molecular makeup of tumors to learn more about how the disease develops and progresses, and to identify patterns that might help predict how individual patients will respond to treatment.
Nodal marginal zone lymphoma varies significantly from patient to patient, and doctors don't yet have reliable ways to predict which patients will do well and which may face more aggressive disease. By studying the genetic changes in tumors and combining that information with patient outcomes, researchers hope to create better tools for predicting disease progression and tailoring treatment plans.
You likely qualify if…
You likely don't qualify if…
You would not need to come in for new visits or procedures. Instead, researchers will collect your existing tumor tissue samples (already taken during your diagnosis) and review your medical records to gather information about your diagnosis, treatments, and how you've responded to therapy. Your samples and information will be coded with a number to protect your privacy, then analyzed to study the genetic features of your lymphoma.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
United States
Argentina